Magle Group highlights solid-state expertise for inhalation development
It helps de-risk drug development by controlling surface amorphicity and relaxation dynamics.
See the latest news and media coverage for Magle Group. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare innovations developer and manufacturer
maglegroup.comLast updated
In short: Magle Group faced financial challenges in early 2026, leading to a strategic refocus and debt negotiations following its merger with Amniotics.
It helps de-risk drug development by controlling surface amorphicity and relaxation dynamics.
They express gratitude for the opportunity and wish everyone a joyful holiday season.
The organization collaborates to open Christmas gift shops in Malmö, Kristianstad and Helsingborg for needy families.
It offers high-purity dextran products including sulphates and derivatives. Customers can view specs, order, and access documentation.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...
A difficult quarter in a year of necessary change Q1 2026 KEY INDICATORSTotal revenue amounted to 71.7 MSEK (85.1)EBITDA equalled -6.6 MSEK (12.8)Operating profit (EBIT...
Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 10 April 2026, held an Extraordinary General Meeting (the "EGM") at the Company's...
The healthcare group Magle Group is carrying out a rights issue that can provide the company with 40 MSEK before costs. The issue guide raises three flags.
Track Magle Group and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Magle Group and other trending companies.